Cargando…

A 3-year prospective randomized clinical trial of alveolar bone crest response and clinical parameters through 1, 2, and 3 years of clinical function of implants placed 4 months after alveolar ridge preservation using two different allogeneic bone-grafting materials

PURPOSE: The aim of this study was to longitudinally evaluate changes in alveolar bone crest (ABC) levels and differences in resorption rates (RR) between the tested grafting materials following alveolar ridge preservation (ARP) after tooth extraction after 1, 2, and 3 years (T1–T8) of clinical func...

Descripción completa

Detalles Bibliográficos
Autores principales: Solakoğlu, Önder, Ofluoğlu, Duygu, Schwarzenbach, Heidi, Heydecke, Guido, Reißmann, Daniel, Ergun, Sertan, Götz, Werner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804085/
https://www.ncbi.nlm.nih.gov/pubmed/35102440
http://dx.doi.org/10.1186/s40729-022-00402-w
_version_ 1784643000690802688
author Solakoğlu, Önder
Ofluoğlu, Duygu
Schwarzenbach, Heidi
Heydecke, Guido
Reißmann, Daniel
Ergun, Sertan
Götz, Werner
author_facet Solakoğlu, Önder
Ofluoğlu, Duygu
Schwarzenbach, Heidi
Heydecke, Guido
Reißmann, Daniel
Ergun, Sertan
Götz, Werner
author_sort Solakoğlu, Önder
collection PubMed
description PURPOSE: The aim of this study was to longitudinally evaluate changes in alveolar bone crest (ABC) levels and differences in resorption rates (RR) between the tested grafting materials following alveolar ridge preservation (ARP) after tooth extraction after 1, 2, and 3 years (T1–T8) of clinical function. METHODS: Patients were randomly assigned to two different bone allografts (group 1 maxgraft(®), group 2 Puros(®)) for ARP. Non-restorable teeth were minimal traumatically extracted. Sockets were augmented with the tested materials and covered with a pericardium membrane. After 4 months of healing, 36 implants were placed and sites were clinically and radiographically monitored in the mesial (ABC-M), the distal (ABC-D, T1–T8), the bucco-lingual (ABC-BL), buccal (ABC-B) and oral (ABC-O) aspect (T1–T4). RESULTS: Changes in (ABC-M), (ABC-D), (ABC-BL), (ABC-B), and (ABC-O) levels showed statistically highly significant differences between T1 and T2 for both bone allografts (p < 0.001). Changes at the ABC-M and ABC-BL levels between T2 and T3 of group 1 showed a statistically significant difference (p < 0.001). Both groups achieved and maintained increased ABC levels without statistically significant differences throughout the monitoring periods of 1–3 years (T6–T8) of clinical function. No failures or adverse events were observed. CONCLUSIONS: To the best of our knowledge, this study is within its limitations the first study to directly compare ABC-changes and differences in RR of two different allogeneic grafting materials for a period of 3 years after ARP. It was demonstrated to be, despite significant differences in RR, a successful method of preserving increased ABC levels through 1, 2, and 3 years of clinical function. Trial registration DRKS00013010, registered 07/30/2018, http://apps.who.int/trialsearch
format Online
Article
Text
id pubmed-8804085
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-88040852022-02-02 A 3-year prospective randomized clinical trial of alveolar bone crest response and clinical parameters through 1, 2, and 3 years of clinical function of implants placed 4 months after alveolar ridge preservation using two different allogeneic bone-grafting materials Solakoğlu, Önder Ofluoğlu, Duygu Schwarzenbach, Heidi Heydecke, Guido Reißmann, Daniel Ergun, Sertan Götz, Werner Int J Implant Dent Research PURPOSE: The aim of this study was to longitudinally evaluate changes in alveolar bone crest (ABC) levels and differences in resorption rates (RR) between the tested grafting materials following alveolar ridge preservation (ARP) after tooth extraction after 1, 2, and 3 years (T1–T8) of clinical function. METHODS: Patients were randomly assigned to two different bone allografts (group 1 maxgraft(®), group 2 Puros(®)) for ARP. Non-restorable teeth were minimal traumatically extracted. Sockets were augmented with the tested materials and covered with a pericardium membrane. After 4 months of healing, 36 implants were placed and sites were clinically and radiographically monitored in the mesial (ABC-M), the distal (ABC-D, T1–T8), the bucco-lingual (ABC-BL), buccal (ABC-B) and oral (ABC-O) aspect (T1–T4). RESULTS: Changes in (ABC-M), (ABC-D), (ABC-BL), (ABC-B), and (ABC-O) levels showed statistically highly significant differences between T1 and T2 for both bone allografts (p < 0.001). Changes at the ABC-M and ABC-BL levels between T2 and T3 of group 1 showed a statistically significant difference (p < 0.001). Both groups achieved and maintained increased ABC levels without statistically significant differences throughout the monitoring periods of 1–3 years (T6–T8) of clinical function. No failures or adverse events were observed. CONCLUSIONS: To the best of our knowledge, this study is within its limitations the first study to directly compare ABC-changes and differences in RR of two different allogeneic grafting materials for a period of 3 years after ARP. It was demonstrated to be, despite significant differences in RR, a successful method of preserving increased ABC levels through 1, 2, and 3 years of clinical function. Trial registration DRKS00013010, registered 07/30/2018, http://apps.who.int/trialsearch Springer Berlin Heidelberg 2022-02-01 /pmc/articles/PMC8804085/ /pubmed/35102440 http://dx.doi.org/10.1186/s40729-022-00402-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Solakoğlu, Önder
Ofluoğlu, Duygu
Schwarzenbach, Heidi
Heydecke, Guido
Reißmann, Daniel
Ergun, Sertan
Götz, Werner
A 3-year prospective randomized clinical trial of alveolar bone crest response and clinical parameters through 1, 2, and 3 years of clinical function of implants placed 4 months after alveolar ridge preservation using two different allogeneic bone-grafting materials
title A 3-year prospective randomized clinical trial of alveolar bone crest response and clinical parameters through 1, 2, and 3 years of clinical function of implants placed 4 months after alveolar ridge preservation using two different allogeneic bone-grafting materials
title_full A 3-year prospective randomized clinical trial of alveolar bone crest response and clinical parameters through 1, 2, and 3 years of clinical function of implants placed 4 months after alveolar ridge preservation using two different allogeneic bone-grafting materials
title_fullStr A 3-year prospective randomized clinical trial of alveolar bone crest response and clinical parameters through 1, 2, and 3 years of clinical function of implants placed 4 months after alveolar ridge preservation using two different allogeneic bone-grafting materials
title_full_unstemmed A 3-year prospective randomized clinical trial of alveolar bone crest response and clinical parameters through 1, 2, and 3 years of clinical function of implants placed 4 months after alveolar ridge preservation using two different allogeneic bone-grafting materials
title_short A 3-year prospective randomized clinical trial of alveolar bone crest response and clinical parameters through 1, 2, and 3 years of clinical function of implants placed 4 months after alveolar ridge preservation using two different allogeneic bone-grafting materials
title_sort 3-year prospective randomized clinical trial of alveolar bone crest response and clinical parameters through 1, 2, and 3 years of clinical function of implants placed 4 months after alveolar ridge preservation using two different allogeneic bone-grafting materials
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804085/
https://www.ncbi.nlm.nih.gov/pubmed/35102440
http://dx.doi.org/10.1186/s40729-022-00402-w
work_keys_str_mv AT solakogluonder a3yearprospectiverandomizedclinicaltrialofalveolarbonecrestresponseandclinicalparametersthrough12and3yearsofclinicalfunctionofimplantsplaced4monthsafteralveolarridgepreservationusingtwodifferentallogeneicbonegraftingmaterials
AT ofluogluduygu a3yearprospectiverandomizedclinicaltrialofalveolarbonecrestresponseandclinicalparametersthrough12and3yearsofclinicalfunctionofimplantsplaced4monthsafteralveolarridgepreservationusingtwodifferentallogeneicbonegraftingmaterials
AT schwarzenbachheidi a3yearprospectiverandomizedclinicaltrialofalveolarbonecrestresponseandclinicalparametersthrough12and3yearsofclinicalfunctionofimplantsplaced4monthsafteralveolarridgepreservationusingtwodifferentallogeneicbonegraftingmaterials
AT heydeckeguido a3yearprospectiverandomizedclinicaltrialofalveolarbonecrestresponseandclinicalparametersthrough12and3yearsofclinicalfunctionofimplantsplaced4monthsafteralveolarridgepreservationusingtwodifferentallogeneicbonegraftingmaterials
AT reißmanndaniel a3yearprospectiverandomizedclinicaltrialofalveolarbonecrestresponseandclinicalparametersthrough12and3yearsofclinicalfunctionofimplantsplaced4monthsafteralveolarridgepreservationusingtwodifferentallogeneicbonegraftingmaterials
AT ergunsertan a3yearprospectiverandomizedclinicaltrialofalveolarbonecrestresponseandclinicalparametersthrough12and3yearsofclinicalfunctionofimplantsplaced4monthsafteralveolarridgepreservationusingtwodifferentallogeneicbonegraftingmaterials
AT gotzwerner a3yearprospectiverandomizedclinicaltrialofalveolarbonecrestresponseandclinicalparametersthrough12and3yearsofclinicalfunctionofimplantsplaced4monthsafteralveolarridgepreservationusingtwodifferentallogeneicbonegraftingmaterials
AT solakogluonder 3yearprospectiverandomizedclinicaltrialofalveolarbonecrestresponseandclinicalparametersthrough12and3yearsofclinicalfunctionofimplantsplaced4monthsafteralveolarridgepreservationusingtwodifferentallogeneicbonegraftingmaterials
AT ofluogluduygu 3yearprospectiverandomizedclinicaltrialofalveolarbonecrestresponseandclinicalparametersthrough12and3yearsofclinicalfunctionofimplantsplaced4monthsafteralveolarridgepreservationusingtwodifferentallogeneicbonegraftingmaterials
AT schwarzenbachheidi 3yearprospectiverandomizedclinicaltrialofalveolarbonecrestresponseandclinicalparametersthrough12and3yearsofclinicalfunctionofimplantsplaced4monthsafteralveolarridgepreservationusingtwodifferentallogeneicbonegraftingmaterials
AT heydeckeguido 3yearprospectiverandomizedclinicaltrialofalveolarbonecrestresponseandclinicalparametersthrough12and3yearsofclinicalfunctionofimplantsplaced4monthsafteralveolarridgepreservationusingtwodifferentallogeneicbonegraftingmaterials
AT reißmanndaniel 3yearprospectiverandomizedclinicaltrialofalveolarbonecrestresponseandclinicalparametersthrough12and3yearsofclinicalfunctionofimplantsplaced4monthsafteralveolarridgepreservationusingtwodifferentallogeneicbonegraftingmaterials
AT ergunsertan 3yearprospectiverandomizedclinicaltrialofalveolarbonecrestresponseandclinicalparametersthrough12and3yearsofclinicalfunctionofimplantsplaced4monthsafteralveolarridgepreservationusingtwodifferentallogeneicbonegraftingmaterials
AT gotzwerner 3yearprospectiverandomizedclinicaltrialofalveolarbonecrestresponseandclinicalparametersthrough12and3yearsofclinicalfunctionofimplantsplaced4monthsafteralveolarridgepreservationusingtwodifferentallogeneicbonegraftingmaterials